Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertensionPHILIPP, Thomas; SMITH, Timothy R; GLAZER, Robert et al.Clinical therapeutics. 2007, Vol 29, Num 4, pp 563-580, issn 0149-2918, 18 p.Article

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure : Results from the valsartan heart failure trial (Val-HeFT)MAGGIONI, Aldo P; LATINI, Roberto; CARSON, Peter E et al.The American heart journal. 2005, Vol 149, Num 3, pp 548-557, issn 0002-8703, 10 p.Article

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan Heart Failure Trial (Val-HeFT) echocardiographic dataWONG, Maylene; STASZEWSKY, Lidia; LATINI, Roberto et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 11, pp 2022-2027, issn 0735-1097, 6 p.Article

N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigsBERNSTEIN, David I; BRAVO, Fernando J; CLARK, Jennifer R et al.Antiviral research. 2011, Vol 92, Num 2, pp 386-388, issn 0166-3542, 3 p.Article

Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase CαXIAO ZENG; HANGMIN XU; GLAZER, Robert I et al.Cancer research (Baltimore). 2002, Vol 62, Num 12, pp 3538-3543, issn 0008-5472Article

Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cellsPARK, Bae-Keun; XIAO ZENG; GLAZER, Robert I et al.Cancer research (Baltimore). 2001, Vol 61, Num 20, pp 7647-7653, issn 0008-5472Article

Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy : A double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adultsPOOL, James L; GLAZER, Robert; WEINBERGER, Myron et al.Clinical therapeutics. 2007, Vol 29, Num 1, pp 61-73, issn 0149-2918, 13 p.Article

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertensionPOLDERMANS, Don; GLAZER, Robert; KARAGIANNIS, Stefanos et al.Clinical therapeutics. 2007, Vol 29, Num 2, pp 279-289, issn 0149-2918, 11 p.Article

Effects of Valsartan alone versus Valsartan/Simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertensionRAJAGOPALAN, Sanjay; ZANNAD, Faiez; RADAUCEANU, Anca et al.The American journal of cardiology. 2007, Vol 100, Num 2, pp 222-226, issn 0002-9149, 5 p.Article

Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFTKRUM, Henry; LATINI, Roberto; COHN, Jay et al.International journal of cardiology. 2007, Vol 119, Num 1, pp 48-53, issn 0167-5273, 6 p.Article

Time to achieve blood-pressure goal : Influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapyWEIR, Matthew R; LEVY, Drew; CRIKELAIR, Nora et al.American journal of hypertension. 2007, Vol 20, Num 7, pp 807-815, issn 0895-7061, 9 p.Article

C-reactive protein in heart failure : Prognostic value and the effect of valsartanANAND, Inder S; LATINI, Roberto; COHN, Jay N et al.Circulation (New York, N.Y.). 2005, Vol 112, Num 10, pp 1428-1434, issn 0009-7322, 7 p.Article

Sustained reduction of aldosterone in response to the angiotensin receptor blocker Valsartan in patients with chronic heart failure results from the Valsartan Heart Failure trialCOHN, Jay N; ANAND, Inder S; LATINI, Roberto et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 11, pp 1306-1309, issn 0009-7322, 4 p.Article

Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates β-catenin and c-Myc, and down-regulates caveolin-1ZHIHUI XIE; XIAO ZENG; WALDMAN, Todd et al.Cancer research (Baltimore). 2003, Vol 63, Num 17, pp 5370-5375, issn 0008-5472, 6 p.Article

Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertensionCALHOUN, David A; LACOURCIERE, Yves; CRIKELAIR, Nora et al.Current medical research and opinion. 2013, Vol 29, Num 8, pp 901-910, issn 0300-7995, 10 p.Article

Inhibition of Peroxisome Proliferator-Activated Receptor γ Increases Estrogen Receptor―Dependent Tumor SpecificationYUZHI YIN; HONGYAN YUAN; XIAO ZENG et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 2, pp 687-694, issn 0008-5472, 8 p.Article

Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical TrialCALHOUN, David A; LACOURCIERE, Yves; YANN TONG CHIANG et al.Hypertension (Dallas, Tex. 1979). 2009, Vol 54, Num 1, pp 32-39, issn 0194-911X, 8 p.Article

Delayed mammary gland involution in MMTV-AKT1 transgenic miceACKLER, Scott; AHMAD, Shakeel; TOBIAS, Christopher et al.Oncogene (Basingstoke). 2002, Vol 21, Num 2, pp 198-206, issn 0950-9232Article

Efficacy of N -methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virusSMEE, Donald F; HURST, Brett L; WONG, Min-Hui et al.Antiviral research. 2007, Vol 76, Num 2, pp 124-129, issn 0166-3542, 6 p.Article

Detection of a mixed-backbone oligonucleotide (GEM 231) in liver and tumor tissues by capillary electrophoresisBANSAL, Reeta; CHEN, Helen X; MARSHALL, John L et al.Journal of chromatography. B, Biomedical sciences and applications. 2001, Vol 750, Num 1, pp 129-135, issn 1387-2273Article

PPARδ Induces Estrogen Receptor-Positive Mammary Neoplasia through an Inflammatory and Metabolic Phenotype Linked to mTOR ActivationHONGYAN YUAN; JIN LU; JUNFENG XIAO et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4349-4361, issn 0008-5472, 13 p.Article

Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug developmentROLLER, Erich; PROPP, Stephanie; GLAZER, Robert I et al.Cancer research (Baltimore). 2006, Vol 66, Num 4, pp 2059-2066, issn 0008-5472, 8 p.Article

Peroxisome proliferator-activated receptor δ and γ agonists differentially alter tumor differentiation and progression during mammary carcinogenesisYUZHI YIN; RUSSELL, Robert G; DETTIN, Luis E et al.Cancer research (Baltimore). 2005, Vol 65, Num 9, pp 3950-3957, issn 0008-5472, 8 p.Article

Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: Design, synthesis, and effects on cardiomyocyte differentiationWEI, Zhi-Liang; PETUKHOV, Pavel A; BIZIK, Fero et al.Journal of the American Chemical Society. 2004, Vol 126, Num 51, pp 16714-16715, issn 0002-7863, 2 p.Article

Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)BARUCH, Lawrence; GLAZER, Robert D; AKNAY, Nora et al.The American heart journal. 2004, Vol 148, Num 6, pp 951-957, issn 0002-8703, 7 p.Article